Stada-led €4bn loan spree could push lev pricing wider
The European leveraged finance market is set to contend with loan deals approaching €4bn for the start of September. Over half of that is for the German pharmaceutical firm Stada — a deal that could help make funding more expensive for everyone else, writes Victor Jimenez.
“Every investor is waiting for the
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com